Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    September 2019
  1. VELAYOS JIMENEZ B, Cuello Garcia R, Del Olmo Martinez L, Macho Conesa A, et al
    Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab.
    Gastroenterol Hepatol. 2019 Sep 2. pii: S0210-5705(19)30168.
    PubMed     Text format    


    August 2019
  2. OLMEDO-MARTIN RV, Gonzalez-Molero I, Olveira G, Amo-Trillo V, et al
    Sunlight exposure in inflammatory bowel disease outpatients: Predictive factors and correlation with serum vitaminD.
    Gastroenterol Hepatol. 2019 Aug 28. pii: S0210-5705(19)30167.
    PubMed     Text format     Abstract available


  3. RODRIGUEZ-LAGO I, Merino O, Lopez de Goicoechea MJ, Aranzamendi M, et al
    Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
    Gastroenterol Hepatol. 2019 Aug 8. pii: S0210-5705(19)30159.
    PubMed     Text format     Abstract available


    May 2019
  4. CASAS DEZA D, Llorente Barrio M, Monzon Baez RM, Lamuela Calvo LJ, et al
    It is not always Crohn's disease: Amebiasis as a differential diagnosis of inflammatory bowel disease.
    Gastroenterol Hepatol. 2019 May 20. pii: S0210-5705(19)30100.
    PubMed     Text format    


  5. PANES J, Gisbert JP
    Efficacy of tofacitinib treatment in ulcerative colitis.
    Gastroenterol Hepatol. 2019 May 14. pii: S0210-5705(19)30094.
    PubMed     Text format     Abstract available


    April 2019
  6. SEDANO MUNOZ R, Quera Pino R, Ibanez Lazo P, Figueroa Corona C, et al
    Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Gastroenterol Hepatol. 2019 Apr 3. pii: S0210-5705(19)30056.
    PubMed     Text format     Abstract available


  7. NUNEZ F P, Quera P R, Gomollon F
    Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
    Gastroenterol Hepatol. 2019 Apr 1. pii: S0210-5705(19)30055.
    PubMed     Text format     Abstract available


    February 2019
  8. RIOS LEON R, Jaureguizar Oriol A, Lopez-Sanroman A, Jimenez Castro D, et al
    Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.
    Gastroenterol Hepatol. 2019;42:104-105.
    PubMed     Text format    


    January 2019
  9. HERNANZ N, Sierra M, Volpato N, Nunez-Gomez L, et al
    Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre.
    Gastroenterol Hepatol. 2019;42:16-22.
    PubMed     Text format     Abstract available


  10. SILVA M, Rios E, Peixoto A, Macedo G, et al
    Intestinal pseudopolyps in a patient with Crohn's disease and renal transplant - An unexpected diagnosis.
    Gastroenterol Hepatol. 2019;42:32-33.
    PubMed     Text format    


  11. GARCIA-MORALES N, Garcia-Campos M, Cordon G, Iborra M, et al
    Intestinal tuberculosis simulating Crohn's disease: Differential diagnosis.
    Gastroenterol Hepatol. 2019;42:29-32.
    PubMed     Text format    


  12. BRUNET E, Martinez de Sola M, Garcia-Iglesias P, Calvet X, et al
    Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.
    Gastroenterol Hepatol. 2019;42:37-38.
    PubMed     Text format    


    December 2018
  13. SEDANO MUNOZ R, Quera Pino R, Lubascher Correa J, Pizarro Jofre G, et al
    Evaluation of de-escalation of anti-TNF-alpha therapy in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Dec 27. pii: S0210-5705(18)30317.
    PubMed     Text format     Abstract available


    November 2018
  14. LLORENTE BARRIO M, Garcia Lopez S, Gilaberte Calzada Y, Monzon Baez RM, et al
    Bilateral pyoderma gangrenosum associated with ulcerative colitis and restorative proctocolectomy.
    Gastroenterol Hepatol. 2018 Nov 20. pii: S0210-5705(18)30285.
    PubMed     Text format    


    October 2018
  15. RODRIGUEZ-LAGO I, Ferreiro-Iglesias R, Nos P, Gisbert JP, et al
    Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30251.
    PubMed     Text format     Abstract available


  16. GUARDIOLA J, Lobaton T, Cerrillo E, Ferreiro-Iglesias R, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018;41:514-529.
    PubMed     Text format     Abstract available


    August 2018
  17. SANCHEZ RODRIGUEZ E, Rios Leon R, Mesonero Gismero F, Albillos A, et al
    Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Aug 11. pii: S0210-5705(18)30205.
    PubMed     Text format     Abstract available


  18. LOPEZ-SANROMAN A, Clofent J, Garcia-Planella E, Menchen L, et al
    Reviewing the therapeutic role of budesonide in Crohn's disease.
    Gastroenterol Hepatol. 2018;41:458-471.
    PubMed     Text format     Abstract available


    July 2018
  19. NUNEZ-GOMEZ L, Mesonero-Gismero F, Albillos-Martinez A, Lopez-Sanroman A, et al
    Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195.
    PubMed     Text format     Abstract available


  20. IBORRA M, Beltran B, Maroto N, Navarro-Cortes P, et al
    Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Gastroenterol Hepatol. 2018 Jul 18. pii: S0210-5705(18)30186.
    PubMed     Text format     Abstract available


    June 2018
  21. YAMAMOTO-FURUSHO JK, Sarmiento-Aguilar A, Garcia-Alanis M, Gomez-Garcia LE, et al
    Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2018 Jun 21. pii: S0210-5705(18)30138.
    PubMed     Text format     Abstract available


    May 2018
  22. GISBERT JP, Chaparro M
    Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
    Gastroenterol Hepatol. 2018 May 9. pii: S0210-5705(18)30108.
    PubMed     Text format     Abstract available


  23. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Text format     Abstract available


    April 2018
  24. SUAREZ FERRER C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, et al
    Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective.
    Gastroenterol Hepatol. 2018 Apr 7. pii: S0210-5705(18)30034.
    PubMed     Text format    


    March 2018
  25. FRAILE LOPEZ M, de Francisco R, Perez-Martinez I, Garcia Garcia B, et al
    Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.
    Gastroenterol Hepatol. 2018 Mar 5. pii: S0210-5705(18)30050.
    PubMed     Text format    


    February 2018
  26. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed     Text format    


  27. MERINO RODRIGUEZ E, Carrera Alonso E, Torralba Gonzalez de Suso M, Sanchez da Silva M, et al
    Ionizing diagnostic radiation exposure in patients with Crohn's disease: A retrospective study in a medium hospital and its predictive factors.
    Gastroenterol Hepatol. 2018;41:97-102.
    PubMed     Text format     Abstract available


    January 2018
  28. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Text format     Abstract available


    December 2017
  29. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Panadero A, Guardiola J, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease pa
    Gastroenterol Hepatol. 2017 Dec 20. pii: S0210-5705(17)30244.
    PubMed     Text format     Abstract available


  30. DE LA PISCINA PR, Delgado E, Duca I, Estrada S, et al
    Acute infection due to Mycobacterium marinum in a patient with ulcerative colitis and metabolic syndrome on infliximab therapy.
    Gastroenterol Hepatol. 2017 Dec 16. pii: S0210-5705(17)30241.
    PubMed     Text format    


    September 2017
  31. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


  32. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Text format     Abstract available


    August 2017
  33. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Text format     Abstract available


  34. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Text format     Abstract available


    July 2017
  35. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed     Text format    


    June 2017
  36. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed     Text format    


  37. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  38. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Text format     Abstract available


    December 2016
  39. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  40. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  41. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  42. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: